Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin
Selim Corbacioglu(Universität Ulm), Klaus‐Michael Debatin(University Hospital Ulm)
Cited by 72
Related Papers
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling
|The Journal of Experimental Medicine|2009|47
Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expression
|Experimental Hematology|2013|12